Howard Chertkow

Dr. Howard Chertkow

Chair in Cognitive Neurology and Innovation Director Kimel Family Centre for Brain Health and Wellness, Baycrest Centre

Director Clinical Trials Unit, Baycrest Centre

Clinical Advisor Centre for Aging + Brain Health Innovation, Baycrest Centre

Research Focus

Dr. Howard Chertkow is a remarkably distinguished cognitive neurologist whose contributions are admired across the world. Dr. Chertkow joins Baycrest and the University of Toronto from Montreal’s McGill University, where he served as Director of the Jewish General Hospital (JGH) and McGill University Bloomfield Centre for Research in Aging and was a Senior Investigator in the Lady Davis Institute for Medical Research. In his practice at the JGH, Dr. Chertkow diagnosed and treated patients with early stage Alzheimer’s disease and other dementias, and helped found and direct Canada’s largest memory clinic.
 
Dr. Chertkow will direct the new Kimel Family Centre for Brain Health and Wellness, a research, education and clinical interdisciplinary program to develop and evaluate the most promising approaches to preventing cognitive decline. As its inaugural Director, Dr. Chertkow will assemble a state-of-the-art Clinical Trials Unit and further develop Baycrest’s translational research program in dementia to test the latest emerging therapies for Alzheimer’s disease and related conditions. He will also serve as a Clinical Advisor to the Centre for Aging + Brain Health Innovation (CABHI), the largest venture of its kind in the global seniors’ care sector.
 
He is an exceptionally prolific researcher in the area of dementia, serving since 2014 as Scientific Director of the Canadian Consortium on Neurodegeneration in Aging (CCNA), which has brought together 400 leading dementia researchers in Canada.  Dr. Chertkow is an elected member of the Canadian Academy of Health Sciences.
 
His areas of research interest include: early diagnosis of Alzheimer’s disease and prediction of deterioration in individuals with mild cognitive impairment (MCI); the structure, organization, and function of the semantic memory component of long term memory, and its deterioration in dementia; localization of language and memory functions in the brain using functional imaging; and therapy of cognitive disorders in Alzheimer’s disease and frontotemporal dementia using neuromodulation approaches.

Publications

Title Source (Journal/Book/Conference) Authors/Presenters Published On Type
Visual selective attention in mild cognitive impairment: Effects of task demands and auditory cues. Journals of Gerontology: Psychological Sciences McLaughlin P M, Anderson ND, Rich JB, Chertkow H, Murtha SJE 1377230400 Journal Article
Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia Canadian Medical Association Journal Hogan DB, Bailey P, Black S, Carswell A, Chertkow H, Clarke B, Cohen C, Fisk JD, Forbes D, Man-Son-Hing M, Lanctot K, Morgan D, Thorpe L 1225774800 Journal Article
Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia Canadian Medical Association Journal Hogan DB, Bailey P, Black S, Carswell A, Chertkow H, Clarke B, Cohen C, Fisk JD, Forbes D, Man-Son-Hing M, Lanctot K, Morgan D, Thorpe L 1223352000 Journal Article
Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia Canadian Medical Association Journal Chertkow H, Massoud F, Nasreddine Z, Belleville S, Joanette Y, Bocti C, Drolet V, Kirk J, Freedman M, Bergman H 1210046400 Journal Article
Diagnosis and treatment of dementia: 2. Diagnosis Canadian Medical Association Journal Feldman HH, Jacova C, Robillard A, Garcia A, Chow T, Borrie M, Schipper HM, Blair M, Kertesz A, Chertkow H 1206417600 Journal Article
Mild cognitive impairment and cognitive impairment, no dementia: Part B, therapy Alzheimer's & Dementia Massoud F, Belleville S, Bergman H, Kirk J, Chertkow H, Nasreddine Z, Joanette Y, Freedman M 1191211200 Journal Article
Imaging biomarkers and their role in dementia clinical trials. Canadian Journal of Neurological Sciences Chertkow H, Black S 1167627600 Journal Article
Progress in clinical neurosciences: Canadian guidelines for the development of antidementia therapies: a conceptual summary Canadian Journal of Neurological Sciences Feldman HH, Gauthier S, Chertkow H, Conn DK, Freedman M, Chris M, 1136091600 Journal Article
A case study of pure word deafness: modularity in auditory processing? Neurocase Pinard M, Chertkow H, Black S, Peretz I 1009861200 Journal Article

Academic Appointments

  • 2018–Present: Chair in Cognitive Neurology and Innovation Director, Kimel Family Centre for Brain Health and Wellness, Baycrest Centre
  • 2018–Present: Director, Clinical Trials Unit, Baycrest Centre
  • 2018–Present: Senior Scientist, Rotman Research Institute, Baycrest Centre
  • 2018–Present: Clinical Advisor, Centre for Aging + Brain Health Innovation, Baycrest Centre
  • 2018–Present: Professor, Neurology, Universty of Toronto

Contact

The Rotman Research Institute
Baycrest
3560 Bathurst Street, 734
Toronto, Ontario
Canada M6A 2E1 Phone: (416) 785-2500 x3956 Email: hchertkow@research.baycrest.org Fax: (416) 785-2862